Syndromic Testing Reagents Statement of Work VA Portland.docx

DOCX document 23 KB Posted

Attached to
6550 - Molecular Diagnostic Laboratory Reagents (Kits)
Solicitation number
36C26026Q0957
Issued by

About this file

This is a Performance Work Statement (PWS) for molecular diagnostic laboratory reagents (kits) to support syndromic testing at VA Portland Health Care System. The VA seeks to establish a Base Year plus four Option Years (total five years, commencing December 1, 2026) for test kits compatible with the VA's existing in-house molecular analyzer located in the Microbiology Department. The kits must utilize multiplex PCR methodology with FDA-cleared assays and provide results within one hour with minimal hands-on setup time (2 minutes or less) in a self-contained system that performs amplification, detection, and analysis automatically.

The required test panels include: (1) Respiratory Panel with up to 20 targets covering viruses (adenovirus, coronaviruses, SARS-CoV-2, influenza, parainfluenza, RSV, human metapneumovirus, rhinovirus) and bacteria (Bordetella species, Chlamydia pneumoniae, Mycoplasma pneumoniae); (2) Gastrointestinal Panel with at least 20 targets including bacterial pathogens (Campylobacter, Salmonella, Vibrio, Shigella, pathogenic E. coli strains), parasites (Cryptosporidium, Giardia, Entamoeba), and viruses (norovirus, rotavirus, adenovirus); (3) Meningitis/CSF Panel with up to 14 targets encompassing bacteria (E. coli K1, Haemophilus influenzae, Neisseria meningitidis, Streptococcus species, Listeria monocytogenes), viruses (HSV-1/2, enterovirus, CMV, HHV-6, VZV), and fungi (Cryptococcus); and (4) Blood Culture Identification Panel with at least 40 targets including gram-negative and gram-positive bacteria, yeasts, and antimicrobial resistance genes (carbapenemases, ESBL, methicillin resistance, vancomycin resistance, colistin resistance). Records management and security accreditation requirements do not apply to this procurement.

View the file

Other files

File Type Posted
S02 Sources Sought 36C26026Q0957.pdf PDF
36C26026Q0957 LineItems A.xlsx XLSX spreadsheet

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Statement of Work (PWS) Request for Molecular Diagnostic Laboratory Reagents (Kits) for Syndromic Testing for Respiratory Panel, Gastrointestinal (GI) panel, Blood culture ID (BCID) panel, and Meningitis (ME) panel testing at VA Portland Health Care System.

Purpose Establish a Base Year plus Four (4) Option Year for reagents (kits) to be used on current in-use Molecular platform. VA owns and has used instrumentation for testing. Needed reagents (kits) are used for detection of needed pathogens found in Respiratory specimens, GI specimens, Blood culture, and CSF (meningitis) specimens.

Scope Vendor will provide Test Kits as needed to perform testing on VA owned molecular analyzer, located in the VA Portland Medical Center Microbiology Department.

The instrument processes kits that must utilize a multiplex PCR (polymerase chain reaction) method, have FDA-cleared assays that simultaneously tests for as many as 20 respiratory pathogen targets, has testing capability to test for common GI pathogens including viruses, bacteria, and parasites with at least 20 targets, at least 40 blood culture identification targets, and up to 14 meningitis/encephalitis targets inclusive of bacteria, viruses and fungi.

The method should have very little hands-on time (2 minutes or less) to set up and have results for respiratory pathogen targets, blood culture, GI pathogens and meningitis/encephalitis targets in one hour. The technique must perform amplification, detection and analysis in one self-contained system. The VA equipment includes software that automatically generates a result for each target in a single report.

Location VA Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR 97239 Period of Performance

Contract Start Date
Base Year
Option Year 1
Option Year 2
Option Year 3
Option Year 4
12/1/2026
12/1/2026 to 11/30/2027
12/1/2027 to 11/30/2028
12/1/2028 to 11/30/2029
12/1/2029 to 11/30/2030
12/1/2030 to 11/30/2031

Records Management All records (administrative and program specific) created during the period of the contract belong to VA Portland (VPORHCS).

The C&A requirements do not apply, and a Security Accreditation Package is not required.

Kit/Panel requirements:

1. Respiratory:

Viruses

· Adenovirus

· Coronavirus 229E

· Coronavirus HKU1

· Coronavirus NL63

· Coronavirus OC43

· Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

· Human Metapneumovirus

· Human Rhinovirus/Enterovirus

· Influenza A, including subtypes

· H1, H3 and H1-2009

· Influenza B

· Parainfluenza Virus 1

· Parainfluenza Virus 2

· Parainfluenza Virus 3

· Parainfluenza Virus 4

· Respiratory Syncytial Virus

Bacteria

· Bordetella parapertussis

· Bordetella pertussis

· Chlamydia pneumoniae

· Mycoplasma pneumoniae

2. GI:

· Campylobacter (C. jejuni/C. coli/C. upsaliensis)

· Clostridium difficile (C. difficile) toxin A/B

· Plesiomonas shigelloides

· Salmonella

· Vibrio (V. parahaemolyticus/V. vulnificus/ V. cholerae), including specific identification of Vibrio cholerae

· Yersinia enterocolitica

· Enteroaggregative Escherichia coli (EAEC)

· Enteropathogenic Escherichia coli (EPEC)

· Enterotoxigenic Escherichia coli (ETEC) lt/st

· Shiga-like toxin-producing Escherichia coli (STEC) stx1/stx2 (including specific identification of the E. coli O157 serogroup within STEC)

· Shigella/ Enteroinvasive Escherichia coli (EIEC)

· Cryptosporidium

· Cyclospora cayetanensis

· Entamoeba histolytica

· Giardia lamblia (also known as G. intestinalis and G. duodenalis)

· Adenovirus F 40/41

· Astrovirus

· Norovirus GI/GII

· Rotavirus A

· Sapovirus (Genogroups I, II, IV, and V)

3. Meningitis (CSF) panel Bacteria:

● Escherichia coli K1

● Haemophilus influenzae

● Listeria monocytogenes

● Neisseria meningitidis

● Streptococcus agalactiae

● Streptococcus pneumoniae Viruses:

● Cytomegalovirus (CMV)

● Enterovirus (EV)

● Herpes simplex virus 1 (HSV-1)

● Herpes simplex virus 2 (HSV-2)

● Human herpesvirus 6 (HHV-6)

● Human parechovirus (HPeV)

● Varicella zoster virus (VZV) Yeast:

● Cryptococcus neoformans/gattii

4. Blood culture ID panel Gram-Negative Bacteria:

· Acinetobacter calcoaceticus-baumannii complex

· Bacteroides fragilis

· Enterobacterales

· Enterobacter cloacae complex

· Escherichia coli

· Klebsiella aerogenes

· Klebsiella oxytoca

· Klebsiella pneumoniae group

· Proteus

· Salmonella

· Serratia marcescens

· Haemophilus influenzae

· Neisseria meningitidis

· Pseudomonas aeruginosa

· Stenotrophomonas maltophilia

Gram-Positive Bacteria:

· Enterococcus faecalis

· Enterococcus faecium

· Listeria monocytogenes

· Staphylococcus

· Staphylococcus aureus

· Staphylococcus epidermidis

· Staphylococcus lugdunensis

· Streptococcus

· Streptococcus agalactiae

· Streptococcus pneumoniae

· Streptococcus pyogenes

Yeast:

· Candida albicans

· Candida auris

· Candida glabrata

· Candida krusei

· Candida parapsilosis

· Candida tropicalis

· Cryptococcus neoformans/gattii

Antimicrobial Resistance Genes:

· Carbapenemases

· IMP

· KPC

· OXA-48-like

· NDM

· VIM

· Colistin Resistance

· mcr-1

· ESBL

· CTX-M

· Methicillin Resistance

· mecA/C

· mecA/C and MREJ (MRSA)

· Vancomycin Resistance

· vanA/B

File details come from the government source that posted it. Updated .